Effects of Dual Cyclooxygenase-2 and Carbonic Anhydrase Inhibition

This study has been terminated.
(A total of three parts were planned for this study. The sponsor funded only Part 1, so that neither Part 2 nor Part 3 of this study has been conducted.)
Sponsor:
Collaborator:
CrystalGenomics, Inc.
Information provided by (Responsible Party):
Carsten Skarke, University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT00780325
First received: October 24, 2008
Last updated: February 5, 2014
Last verified: February 2014